Patents by Inventor Tiffany L. Halo

Tiffany L. Halo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-TNF COMPOUNDS
    Publication number: 20200339996
    Abstract: TNF? antisense oligonucleotides are provided herein. Methods of treating TNF? diseases or disorders using the TNF? antisense oligonucleotides and related products are provided.
    Type: Application
    Filed: July 16, 2020
    Publication date: October 29, 2020
    Applicant: Exicure, Inc.
    Inventors: Christopher C. Mader, Tiffany L. Halo, Sergei Gryaznov, Richard Kang, Weston Daniel
  • Anti-TNF compounds
    Patent number: 10760080
    Abstract: TNF? antisense oligonucleotides are provided herein. Methods of treating TNF? diseases or Initial Screen of Phosphodiester disorders using the TNF? antisense oligonucleotides and related products are provided.
    Type: Grant
    Filed: January 16, 2019
    Date of Patent: September 1, 2020
    Assignee: Exicure, Inc.
    Inventors: Christopher C. Mader, Tiffany L. Halo, Sergei Gryaznov, Richard Kang, Weston Daniel
  • ANTI-TNF COMPOUNDS
    Publication number: 20190211338
    Abstract: TNF? antisense oligonucleotides are provided herein. Methods of treating TNF? diseases or disorders using the TNF? antisense oligonucleotides and related products are provided.
    Type: Application
    Filed: January 16, 2019
    Publication date: July 11, 2019
    Applicant: Exicure, Inc.
    Inventors: Christopher C. Mader, Tiffany L. Halo, Sergei Gryaznov, Richard Kang, Weston Daniel
  • Anti-TNF compounds
    Patent number: 10208310
    Abstract: TNF? antisense oligonucleotides are provided herein. Methods of treating TNF? diseases or disorders using the TNF? antisense oligonucleotides and related products are provided.
    Type: Grant
    Filed: October 6, 2015
    Date of Patent: February 19, 2019
    Assignee: Exicure, Inc.
    Inventors: Christopher C. Mader, Tiffany L. Halo, Sergei Gryaznov, Richard Kang, Weston Daniel
  • IMMUNO-REGULATORY LIPID CONTAINING SPHERICAL NUCLEIC ACIDS
    Publication number: 20180042848
    Abstract: Immunoregulatory spherical nucleic acids (irSNAs) composed of a lipid containing core and an inert Nucleic non-TLR antagonistic oligonucleotide shell are provided. Acid Shell These it-SNAs are useful for modulating an immune response.
    Type: Application
    Filed: February 18, 2016
    Publication date: February 15, 2018
    Applicant: Exicure, Inc.
    Inventors: Sergei Gryaznov, Aleksandar Filip Radovic-Moreno, Christopher C. Mader, Tiffany L. Halo, Richard Kang, Subbarao Nallagatla, Clayton Rische, Sagar Anantatatmula
  • ANTI-TNF COMPOUNDS
    Publication number: 20170306331
    Abstract: TNF? antisense oligonucleotides are provided herein. Methods of treating TNF? diseases or Initial Screen of Phosphodiester disorders using the TNF? antisense oligonucleotides and related products are provided.
    Type: Application
    Filed: October 6, 2015
    Publication date: October 26, 2017
    Inventors: Christopher C. Mader, Tiffany l. Halo, Sergei Gryaznov, Richard Kang, Weston Daniel
  • SPHERICAL NUCLEIC ACID-BASED CONSTRUCTS AS IMMUNOREGULATORY AGENTS
    Publication number: 20160194642
    Abstract: Aspects of the invention relate to nanoscale constructs and related methods and compositions thereof. The compositions of the invention are useful for treating disorders that are sensitive to levels of immune cell activation, such as autoimmune disease or other inflammation based disease or disorder.
    Type: Application
    Filed: July 25, 2014
    Publication date: July 7, 2016
    Applicant: Exicure, Inc
    Inventors: Sergei Gryaznov, Christopher C. Mader, Tiffany L. Halo, Aleksandar Filip Radovic-Moreno, Clayton Rische, Sagar Anantatmula